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Hepatitis C virus (HCV) NS3 protein contains at least three enzymatic activities: NS2-3 protease, NS3 serine protease, and
NTPase/RNA helicase. It has been shown that NS2/3 cleavage is mediated by NS2-3 protease, whereas NS3 serine protease
is responsible for the other four cleavage sites of the nonstructural (NS) region. In this study, we showed that the internal
cleavage of NS3 protein produced two products of 49 kDa (NS3a) and 23 kDa (NS3b) when the entire NS3 region (aa
1027–1657) or the whole open reading frame (aa 1–3010) was expressed in mammalian and insect cells. By means of
site-directed mutagenesis, we demonstrated that NS3a/NS3b cleavage occurs within the RNA helicase sequence motif that
is highly conserved in the Flaviviridae family and that neither NS2-3 protease nor NS3 serine protease was responsible for
this cleavage. The NS3 protease of flaviviruses, dengue virus type 2, for example, has been shown to mediate the internal
cleavage of NS3. The NS3 proteins of HCV and dengue virus may thus be cleaved internally at the same sequence by
different mechanisms of proteolysis. Also discussed is a possible role for the internal processing of HCV NS3 in the viral life
cycle and its pathogenesis. © 1999 Academic Press
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aINTRODUCTION
Hepatitis C virus (HCV) is a major causative agent of
osttransfusion and sporadic non-A, non-B hepatitis
Choo et al., 1989; Kuo et al., 1989). The majority of
CV-infected individuals develop chronic hepatitis. This
requently leads to liver cirrhosis and hepatocellular car-
inoma (Saito et al., 1990).
HCV is a positive-stranded RNA virus that belongs to
he Flaviviridae family (Choo et al., 1989). Its 9.5-kb ge-
ome contains a large open reading frame that encodes
t least 10 viral proteins in the order NH2-C-E1-E2-p7-
S2-NS3-NS4A-NS4B-NS5A-NS5B-COOH. The polypro-
ein is then processed by host signalase and viral pro-
eases. Processing at the core/E1, E1/E2, E2/p7, and
7/NS2 junctions is mediated by a host signal peptidase
Hijikata et al., 1991; Lin et al., 1994; Mizushima et al.,
994). Processing at the NS2/NS3 junction is an inter-
olecular cleavage that requires the C-terminal domain
f NS2 and the N-terminal domain of NS3 protein (Hi-
ikata et al., 1993; Grakoui et al., 1993b). The viral serine
rotease located in the N-terminal domain of NS3
leaves the remaining junctions in the nonstructural re-
ion of the polyprotein, including the cis-cleavage at the
S3/NS4A junction and the trans-cleavage at the NS4A/
S4B, NS4B/NS5A, and NS5A/NS5B junctions. The
1 To whom correspondence and reprint requests should be ad-
aressed. Fax: 81-3-5285-1161. E-mail: tmiyam@nih.go.jp.
315-terminal domain of NS3 has both NTPase and helicase
ctivities (Kim et al., 1995). The NS3 protein is a multi-
unctional protein, required for viral polyprotein process-
ng and virus replication. The crystal structures of HCV
S3 serine protease and helicase revealed novel fea-
ures, including a structural zinc-binding site and a long
-terminus that interacts with neighboring molecules by
inding to a hydrophobic surface patch (Love et al., 1996;
im et al., 1996; Yao et al., 1997). It is of interest to study
ow the NS3 protein determines its multiple function.
In this study, we have found that the NS3 protein was
nternally cleaved within an RNA helicase motif and have
nalyzed the mechanism of this processing.
RESULTS
nternal cleavage of the NS3 protein in insect cells
To express the entire open reading frame (ORF) of
CV, we utilized the baculovirus Autographa californica
uclear polyhedrosis virus (AcNPV) expression system.
n5 cells were infected with Ac394 (Aizaki et al., in
reparation) (Fig. 1), a recombinant baculovirus express-
ng a full-length HCV ORF (aa 1 to 3010). We used wild-
ype baculovirus AcNPV as a negative control. By West-
rn blotting with specific polyclonal antibodies and
onoclonal antibodies, properly processed proteins
rom core to NS5B proteins were detected in the cells
nfected with Ac394 (Aizaki et al., in preparation). Pro-
eins of 72 and 49 kDa were immunoprecipitated by an
nti-NS2/NS3 rabbit polyclonal antiserum directed
gainst the C-terminal portion of NS2 and the N-terminal
0042-6822/99 $30.00
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316 SHOJI ET AL.hird of NS3 (aa 990 to 1243) (Fig. 2A). The 72-kDa protein
s the full-size NS3. The 49-kDa protein is predicted to be
n N-terminal portion of the further processed NS3 pro-
eins and is designated NS3a.
To analyze further processing of the NS3 protein, Tn5
FIG. 1. Expression plasmids and transfer vectors. The structure of the
omains are indicated by arrows. The structural regions of the HCV g
y open boxes. Coding regions of recombinant baculoviruses and exp
he positions of the amino acids. The names of recombinant baculov
onstruct represents an amino acid substitution. AcNS3R1488A, subs
c2952H1083A, substitution with His1083 to Ala. Ac2952C993A, substit
FIG. 2. Internal cleavage of the NS3 protein in insect cells. (A) Tn5
5S-label and immunoprecipitated with anti-NS2/NS3 polyclonal antibo
rotein (NS3) and processed product (NS3a) detected by anti-NS2/NS3
cNPV (lanes 1) were analyzed by Western blotting by using anti-NS2/NS3 pells were infected with AcNS3 (Fig. 1), a recombinant
aculovirus expressing aa 1027 to 1657, which encom-
assed the entire NS3 region. The infected cells were
nalyzed again by Western blotting with the anti-NS2/
S3 and anti-NS3C polyclonal antibodies. The anti-NS3C
enome is shown at the top. NS2-3 protease and NS3 serine protease
are indicated by gray boxes. The nonstructural regions are indicated
plasmids are shown below. The numbers on the white bars indicate
and expression plasmids are shown on the left. The asterisk in the
with Arg1488 to Ala. AcNS3R1496A, substitution with Arg1496 to Ala.
ith Cys993 to Ala. pCAGNS3R1488A, substitution with Arg1488 to Ala.
fected with Ac394 (lane 2) or AcNPV (lane 1) were labeled with Tran
numbers on the left indicate molecular sizes (kDa). The full-size NS3
dy are indicated by arrows. Tn5 cells infected with AcNS3 (lanes 2) orHCV g
enome
ression
iruses
titutioncells in
dy. The
antibo
olyclonal antibody (B) or anti-NS3C polyclonal antibody (C).
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317INTERNAL PROCESSING OF HEPATITIS C VIRUS NS3 PROTEINolyclonal antibody was raised against the C-terminal
ortion of the NS3 protein spanning from aa 1565 to 1657.
he 72- and 49-kDa proteins were detected with anti-
S2/NS3 antibody (Fig. 2B). On the other hand, 72- and
3-kDa proteins were detected by the anti-NS3C anti-
ody (Fig. 2C). Therefore, the 23-kDa protein was con-
idered to be a C-terminal portion of the further pro-
essed NS3 protein and was designated NS3b. These
esults also indicated that the majority of the expressed
S3 protein remained uncleaved under the conditions
sed.
equence alignment of the putative cleavage site
etween NS3a and NS3b
The above immunoblot analyses using N-terminal-
nd C-terminal-specific antibodies against NS3 suggest
hat the further cleavage site between NS3a and NS3b
ust exist within the C-terminal region of NS3. HCV NS3
NA helicase belongs to the DEAD box NTPase/RNA
elicase family (Choo et al., 1991; Gorbalenya et al.,
989). The DEAD box protein family has eight highly
onserved motifs and consists of three subfamilies,
EAD proteins, DEAH proteins, and DEXH proteins. The
CV NS3 protein has a sequence motif of DECH, which
elongs to the DEXH protein subfamily. The HCV NS3
rotein has sequence motifs including XXXXXGKS,
ECH, TAT, XXGXX, and QRRGRTGR.
Interestingly, similar processed forms of NS3 were
etected in tick-borne encephalitis virus (TBE)-infected
ells and also in Dengue virus type 2 (DEN 2)-infected
ells (Falgout et al., 1991; Pugachev et al., 1992). It was
hown that the internal cleavage of the DEN 2 NS3
rotein occurs at QRR1933/GR within its RNA helicase
otif (Keng and Wright, 1997). We compared the C-ter-
inal region of NS3s of HCV, flaviviruses, and pestivi-
uses. As shown in Fig. 3, this final RNA helicase motif is
ompletely conserved among all the HCV genotypes (1a
o 6b). It is also notable that this sequence is highly
onserved in the Flaviviridae family. We thus predicted
hat the HCV NS3 protein may be cleaved into NS3a and
S3b at the QRR1488/GRTGR site as was shown in DEN
-infected cells (Fig. 3, arrow).
utational analyses of the putative NS3a/NS3b site
n insect cells
Using site-directed mutagenesis, we determined that
CV NS3 is cleaved at the putative NS3a/NS3b site,
RR1488/GRTGR. We constructed two mutant baculovi-
uses, AcNS3R1488A, possessing a single amino acid
utation in the putative cleavage site (Arg1488 to Ala),
nd AcNS3R1496A, a negative control (Arg1496 to Ala)
Fig. 1). In Tn5 cells infected with AcNS3 or
cNS3R1496A, full-size NS3, NS3a, and NS3b were de-
ected (Fig. 4, lanes 2 and 4). In contrast, neither NS3a
or NS3b was detected in the cells infected with TcNS3R1488A (Fig. 4, lane 3). These data strongly sug-
est that the NS3 protein is cleaved into NS3a and NS3b
t the QRR1488/GRTGR site.
nternal cleavage of the NS3 protein in mammalian
ells
To confirm that the NS3 protein is cleaved at the same
ite in mammalian cells as in insect cells, we constructed
xpression plasmids pCAGNS3 and pCAGNS3R1488A.
93T cells were transfected with pCAGNS3 or
CAGNS3R1488A. As a negative control, cells were trans-
ected with a vector plasmid without insertion, pCAG(BglII)
Aizaki et al., in preparation). In 293T cells transfected with
CAGNS3, full-size NS3, NS3a, and NS3b were detected
Fig. 5, lane 2). In contrast, neither NS3a nor NS3b was
etected in 293T cells transfected with pCAGNS3R1488A,
ndicating that mutation of Arg1488 to Ala abolished the
leavage at the putative NS3a/NS3b site (Fig. 5, lane 3).
FIG. 3. Sequence alignment of the putative internal cleavage site in
S3 of various HCV genotypes, flaviviruses, and pestiviruses. Amino
cid sequences within NS3 of various HCV genotypes, flaviviruses, and
estiviruses are aligned using the single-letter code. A dot indicates
he residue identical to that in HCV-NIHJ1. The putative internal cleav-
ge site in NS3 is indicated by an arrow. Abbreviations and sequences
sed for NS3 alignments are as follows: HCV-NIHJ1 (Aizaki et al., 1998);
K (Takamizawa et al., 1991); HCV-1 (Choo et al., 1991); HC-J6 (Okamoto
t al., 1991); HC-J8G (Okamoto et al., 1992); BEBE1 (Nakao et al., 1996);
ZL1 (Sakamoto et al., 1994); TrKj (Chayama et al., 1994); ED43 (Cham-
erlain et al., 1997); HC-G9 (Okamoto et al., 1994); euhk2 (Adams et al.,
997); DEN2, dengue type 2, PR159 S1 strain (Hahn et al., 1988); TBE,
ick-borne encephalitis virus, western subtype (Mandl et al., 1989); JE,
apanese encephalitis virus Beijing 1 strain (Hashimoto et al., 1988); YF,
ellow fever virus 17D strain (Rice et al., 1985); BVDV, bovine viral
iarrhea virus NCP1 (Meyers, 1991); CSFV, classical swine fever virus
Meyers and Thiel, 1995). A part of this sequence alignment was a
odification of the alignment by Arias et al. (1993). The QRRGRTGR
otif is boxed. The numbers on the sequence indicate the position of
he amino acids of HCV-NIHJ1.hese results indicated that the NS3 protein was cleaved at
t
i
c
t
p
r
c
c
i
A
t
p
N
H
t
n
r
s
a
A
p
a
A
A
A
t
n
h
(
i
i
p
a
p
a
318 SHOJI ET AL.he QRR1488/GRTGR site in mammalian cells as well as in
nsect cells. Without proper quantitative analysis, it is not
lear whether the level of cleavage in mammalian cells is
he same as in insect cells.
Pulse–chase analysis demonstrated that NS3a was
roduced soon after the 20-min labeling and that the
atio of NS3a to NS3 did not change during the 60-min
hase period (data not shown). It is thus possible that a
onstant amount of NS3 is cotranslationally processed
nto NS3a and NS3b.
nalysis of mechanism for the internal cleavage of
he NS3 protein
We then tested whether cellular protease(s) or HCV
rotease(s) is involved in the further processing of the
FIG. 4. Immunoblot analysis of the internal cleavage of NS3 in insec
arvested at 60 h postinfection and analyzed by immunoblot analysis by
B). The full-size NS3 protein (NS3), processed products NS3a detecte
ndicated by arrows. Lanes 1, AcNPV-infected cells; lanes 2, AcNS3-in
nfected cells. The numbers on the left indicate molecular sizes (kDa).
FIG. 5. Immunoprecipitation analysis of the internal cleavage of NS
CAGNS3R1488A were labeled with Tran 35S-label and immunoprec
ntibody (B). The immunoprecipitates were subjected to SDS–PAGE
CAGNS3R1488A. The numbers on the left indicate molecular sizes (k
nti-NS2/NS3 antibody, and NS3b detected by anti-NS3C antibody are indicaS3 described above. To determine the possibility of
CV proteases’ role, we introduced site-directed muta-
ions into NS2-3 and NS3 serine proteases. A recombi-
ant baculovirus, Ac2952, carried almost all the NS2/NS3
egion (aa 848 to 1652) (Fig. 1). To inactivate the NS3
erine protease, aa 1083, histidine, was converted to
lanine. This mutant baculovirus was designated
c2952H1083A (Figs. 1 and 6A). To inactivate the NS2-3
rotease activity, aa 993, cysteine, was converted to
lanine. This mutant baculovirus was designated
c2952C993A (Figs. 1 and 6A). We confirmed that
c2952 expressed NS3 serine protease activity, whereas
c2952H1083A expressed an inactive NS3 serine pro-
ease by using NS5A/NS5B regions as a substrate (data
ot shown). In the cells infected with Ac2952C993A, the
Tn5 cells infected with AcNS3, AcNS3R1488A, or AcNS3R1496A were
anti-NS2/NS3 polyclonal antibody (A) or anti-NS3C polyclonal antibody
nti-NS2/NS3 antibody, and NS3b detected by anti-NS3C antibody are
cells; lanes 3, AcNS3R1488A-infected cells; lanes 4, AcNS3R1496A-
ammalian cells. 293T cells transfected with pCAGBgIII, pCAGNS3, or
with anti-NS2/NS3 polyclonal antibody (A) or anti-NS3C polyclonal
utoradiography. Lanes 1, pCAG(BgIII); lanes 2, pCAGNS3; lanes 3,
e full-size NS3 protein (NS3), processed products NS3a detected byt cells.
using
d by a
fected3 in m
ipitated
and a
Da). Thted by arrows.
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319INTERNAL PROCESSING OF HEPATITIS C VIRUS NS3 PROTEINrocessing between the NS2/NS3 junction did not occur,
or did we detect the resulting C-terminal truncated NS2
rotein (NS2DN) (Fig. 6B, lane 4). This indicated that the
S2-3 protease expressed by Ac2952C993A was inac-
ive and does not cleave the NS2/3 junction.
As shown in Fig. 6B (lanes 2 and 3), the NS3a protein
as detected in the cells infected with Ac2952 or
c2952H1083A, indicating that the internal cleavage of
he NS3 protein occurs even when the NS3 serine pro-
ease is inactive. The 68-kDa protein, which was ob-
erved in the cells infected with Ac2952C993A (Fig. 6B,
ane 4), is considered to be produced by processing the
952 protein at the NS3a/NS3b site, since the inactivated
S2-3 protease did not cleave at the NS2/NS3 site in the
ells infected with Ac2952C993A. NS3b protein trun-
ated by five amino acids at the C-terminal (NS3bDC)
as detected in the cells infected with Ac2952,
c2952H1083A, or Ac2952C993A, irrespective of activity
f the viral proteases (Fig. 6C, lanes 2, 3, and 4). From
hese data, we have concluded that the HCV proteases
re not responsible for the cleavage at the NS3a/NS3b
ite and that this cleavage is probably mediated by a
ellular protease.
DISCUSSION
Further processing of the NS3 protein was investi-
FIG. 6. Analysis of the mechanism for the internal cleavage of the N
ere analyzed by immunoblot analyses by using anti-NS2/NS3 polyclon
ndicate molecular sizes (kDa). Lanes 1, AcNPV-infected cells; lanes
c2952C993A-infected cells. The precursor protein 2952 and processed
y arrows.ated by transient expression in both mammalian and insect cells to determine the internal cleavage site within
he NS3 protein and to examine the mechanism of its
rocessing. We found that the NS3 protein was cleaved
nto NS3a and NS3b in both insect and mammalian cells.
urther studies using site-directed mutants revealed that
he NS3 protein was specifically processed at the
RR1488/GRTGR site within the RNA helicase motif. Even
hen the NS2-3 protease and NS3 serine protease are
nactive, internal cleavage of the NS3 protein occurs,
uggesting that HCV proteases are not responsible for
he internal cleavage and that this cleavage is probably
ediated by cellular protease.
We observed that the NS3 protein was processed at
he QRR1488/GRTGR site in both insect and mammalian
ells, indicating that the NS3 protein is internally pro-
essed very specifically. Specific cleavage of the NS3
rotein at the QRR1488/GRTGR site is considered to occur
n HCV-infected cells.
The functional role of the internal cleavage within the
S3 protein is not known. However, it is of interest that
nternal cleavage within the NS3 protein was also re-
orted in cells infected with DEN-2 and TBE (Pugachev
t al., 1992; Arias et al., 1993). It has been shown that
roduction of NS3a for DEN-2 resulted from cleavage at
he QRR/GR site within an RNA helicase sequence motif
Keng and Wright, 1997). Our data demonstrated that the
tein. Tn5 cells infected with Ac2952, Ac2952H1083A, or Ac2952C993A
body (A) or anti-NS3C polyclonal antibody (B). The numbers on the left
2952-infected cells; lanes 3, Ac2952H1083A-infected cells; lanes 4,
ts NS3DC, NS3a, NS3bDC, NS2DN, and NS2DN 1 NS3a are indicatedS3 pro
al anti
2, Ac
producnternal cleavage within the NS3 protein of HCV also
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320 SHOJI ET AL.ccurred within the RNA helicase motif. The internal
leavage within the NS3 protein may be a common
henomenon among the Flaviviridae family and may play
n important role in their life cycle. This motif is proposed
o have a role in ATP hydrolysis and RNA binding. It was
hown that Arg1488 was important for RNA binding and
NA helicase activity (Kim et al., 1997). The crystal struc-
ure of the HCV RNA helicase domain revealed that the
onserved QRRGRTGR sequence spans the C-terminus
f a short a-helix and the first segment of a more ex-
ended loop (Yao et al., 1997). Residues required for RNA
inding are localized on the C-terminal region. Internal
leavage within the NS3 protein could consequently in-
ctivate the RNA-dependent RNA helicase, providing a
echanism for regulation of viral RNA synthesis.
Arias et al. (1993) proposed that NS3 was further
leaved by NS3 serine protease derived from DEN-2. In
ontrast, our data demonstrated that HCV proteases are
ot responsible for the internal cleavage. The cleavage
ites recognized by a trypsin-like serine protease are
sually characterized by two basic amino acids followed
y a residue with a short side chain (Arg, Ala, or Gly). The
ollowing amino acid is also a basic residue, either Lys
r Arg. At the sites cleaved by flavivirus serine proteases,
nly the P2, P1, and P19 are highly conserved among all
laviviruses. Basic residues (Arg or Lys) are usually found
t the P2 and P1 positions, with the exception of Gln at
he P2 position of the 2B/3 site of the four dengue virus
erotypes. Our proposed internal cleavage site within
S3 is consistent with this sequence. The N-terminal
omain of NS3 derived from HCV has been found to
ontain the catalytic motif of a trypsin-like serine pro-
ease (Miller and Purcell, 1990). The positions of His1083,
sp1107, and Ser1165 are strictly conserved among all
CVs. Their relative order and spacing in the sequence
orrespond to the catalytic triad of the trypsin family.
owever, the NS3 serine protease exhibits highly un-
sual features for a trypsin-like protease. Cleavage
pecificity of this enzyme is distinct from that of the
lavivirus enzymes. Polar residues (Cys or Thr) are found
t the P1 position, and acidic residues (Glu or Asp) are
ound at the P6 position (Grakoui et al., 1993a). Similar to
he flavivirus enzymes, residues with small side chains,
er or Ala, seem to be preferred at the P19 position.
hese observations support the conclusion that HCV
S3 serine protease is not responsible for the cleavage
t the QRR1488/GRTGR site. Therefore, the internal cleav-
ge in the NS3 protein is probably mediated by cellular
rotease.
It is unknown whether the internal cleavage within
S3 affects the NS3 serine protease activity. The NS3a
rotein is presumably an active protease, because pro-
eolysis has been determined in a number of expression
ystems containing truncated forms of NS3 (Hijikata et
l., 1991; Grakoui et al., 1993a; Tomei et al., 1993; Suzuki
t al., 1995; Shoji et al., 1995). Little is known about the 1athogenic effects of the HCV NS3 protein on host cells.
orowski et al. (1996) have shown that 1487RRGRT-
RGRRGITR in the HCV NS3 region has a sequence
ighly similar to the inhibitory site of the heat-stable
nhibitor of cAMP-dependent protein kinase (PKA) and to
he autophosphorylation site in the hinge region of the
KA type II regulatory domain. It has been shown that
acterially expressed HCV NS3 protein containing amino
cids 1189 to 1525 can bind to the catalytic subunit of
KA and inhibit the translocation of the C-subunit into the
ucleus (Borowski et al., 1997). Pathogenic effects of a
umber of viruses result from the disturbance of intra-
ellular signal transduction cascades caused by viral
ntigens. Our data suggest that the internal cleavage at
he NS3a/NS3b site could reveal this sequence, which
as the potential to inhibit PKA function. It should be of
nterest to determine whether production of the NS3b
rotein affects the PKA function and cause pathogenic
ffects on host cells. Recently infectious cDNA clones of
CV have been established (Kolykhalov et al., 1997;
anagi et al., 1998). It is important to study the biological
unctions and pathogenic effects of the internally cleaved
CV NS3 protein by mutation analyses at the NS3a/
S3b site of the infectious cDNA clones.
MATERIALS AND METHODS
ells and viruses
Recombinant baculoviruses were constructed by use
f the transfer vector pAcYM1 (Matsuura et al., 1987).
cNPV and recombinant baculoviruses were grown and
ssayed in Spodoptera frugiperda (Sf) 9 cells in TC100
edium (Gibco Laboratories, Grand Island, NY) supple-
ented with 0.26% bactotryptose broth (Difco, Detroit,
I), 100 mg of kanamycin/ml, and 10% fetal bovine se-
um. Recombinant baculoviruses were isolated by co-
ransfection with infectious viral DNA as described pre-
iously (Matsuura et al., 1987). Recombinant baculovi-
uses were amplified in Sf9 cells and infectious titers
ere determined by plaque assay. Trichoplusia ni (Tn) 5
ells were grown in Ex-cell 405 (BSC Biosciences, Le-
exa, KS). 293T cells were maintained in Dulbecco’s
odified Eagle’s medium (DMEM) (Gibco) containing 2
mol of L-glutamine, penicillin (50 IU/ml), streptomycin
50 mg/ml), and 10% fetal bovine serum.
onstruction of plasmids
All expression plasmids were derivatives of pET21b
Novagen, Madison, WI), pCAG(BgIII) (Niwa et al., 1991;
izaki et al., in preparation), pAcYM1 (Matsuura et al.,
987), and pGEX-4T-1 (Pharmacia Biotech, Uppsala,
weden). Type 1b HCV cDNA clone, HCV NIH-J1, was
erived from a blood sample of a healthy HCV carrier
Kubo et al., 1990; Takeuchi et al., 1990; Aizaki et al.,
998). Transfer vector pcdAc394 encodes an entire ORF
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321INTERNAL PROCESSING OF HEPATITIS C VIRUS NS3 PROTEINf the HCV genome from nt 341 to 9370 (aa 1 to 3010)
Aizaki et al., 1998; Aizaki et al., in preparation). pETNS3
as derived from polymerase chain reaction (PCR) am-
lification of nt 3418 to 5311 (aa 1027 to 1657) with
equence-specific primers, using plasmid pNIHJ1 (Aizaki
t al., 1998) as the template. The resultant pETNS3 was
xpected to express the full-size NS3 protein. Specific
rimers were as follows: sense primer, 59-AAGATATCAT-
GCGCCCATCACGGC-39; antisense primer, 59-AACTC-
AGAGTGACGACCTCTAGGT-39. All constructs were
onfirmed by sequencing analysis after PCR. An EcoRV
nd XhoI fragment of the amplified DNA fragment was
loned into the expression vector of pET21b, which had
een cleaved with NdeI, blunted with Klenow polymer-
se, and digested with XhoI. Site-directed mutant
ETNS3R1488A (Arg1488 to Ala), possessing a single
mino acid mutation in the putative cleavage site, and a
egative control pETNS3R1496A (Arg1496 to Ala) were
btained by inserting mutations in PCR primers. The
ubstitution mutation of Arg to Ala was made by site-
irected mutagenesis according to the method de-
cribed by Ito et al. (1991). The specific primers used to
ntroduce the mutation were as follows: R1488A, 59-GTC-
TACCTGCCCGCTGCGT-39, R1496A, 59-TAGATGCCTGC-
CTGCCCCT-39. To construct transfer vector pAcNS3, a
baI–Bpu1102I fragment derived from pETNS3 after
reatment with Klenow polymerase was cloned into
he SmaI site of pAcYM1. pAcNS3R1488A and
AcNS3R1496A were constructed similarly. pCAGNS3
as obtained by cloning into the BglII site of pCAGBgIII
he XbaI–Bpu1102I fragment derived from pETNS3 after
reatment of both DNA fragments with Klenow polymer-
se. pCAGNS3R1488A was constructed similarly.
Ac2952 encodes the HCV sequence from aa 847 to
652 (Matsuura et al., 1994).
To inactivate HCV NS2-3 protease or NS3 serine pro-
ease, specific mutations were created by PCR using
lasmid pUC3241 (Suzuki et al., 1995) as the template. A
ite-directed mutant in the catalytic histidine (His1083 to
la), pAc3440H1083A, was obtained by inserting the
peI–NdeI fragment of modified pUC3241 (Suzuki et al.,
995). pAc2952H1083A was constructed by inserting the
utant DNA fragment from pAc3440H1083A (Suzuki et
l., 1995) by using restriction sites SpeI–NdeI flanking the
utation and was subsequently sequenced. A site-di-
ected mutant in the catalytic cysteine, pAc2952C993A,
as obtained by inserting the mutant DNA fragment by
sing restriction sites SacII–NruI flanking the mutation
nd was subsequently sequenced. The specific primers
sed to introduce the mutation were as follows: H1083A,
9-CGGCACCGGCAAAGACAGTCCA-39; C993A, 59-AAT-
TCCCCAGCCGCCGC-39. pAc2952H1083A is the mutant
acking NS3 serine protease (Grakoui et al., 1993a; Su-
uki et al., 1995). pAc2952C993A is the mutant lacking
S2-3 protease (Hijikata et al., 1993; Grakoui et al.,993b). nTo generate an antiserum against the C-terminal re-
ion of the NS3 protein, pGEX5053 was constructed. An
hoI–StuI fragment of pETNS3 was ligated into the
maI–XhoI site of pGEX-4T-1. pGEX5053 encodes the
CV sequence from nt 5031 to 5311 (aa 1565 to 1657).
ntibodies
Anti-NS2/NS3 polyclonal antibody was raised against
he recombinant protein of the C-terminal portion of NS2
o the N-terminal third of NS3 (aa 990 to 1243) expressed
n Escherichia coli (Matsuura et al., 1994). Anti-NS3C
olyclonal antibody was raised against the recombinant
rotein GST-5053. E. coli DH5a cells were transformed
ith pGEX5053. The GST fusion protein GST-5053, con-
aining the C-terminal region of the NS3 protein (aa 1565
o 1657), was induced with 0.6 mM isopropyl-b-D-thioga-
actopyranoside. The GST-5053 fusion protein was affin-
ty purified on a glutathione–Sepharose CL4B column
Pharmacia, Tokyo, Japan).
xpression in insect cells and mammalian cells
Tn5 cells were infected with the recombinant baculo-
iruses at a multiplicity of 5 PFU/cells in 35-mm tissue
ulture dishes and incubated at 26.5°C as described
reviously (Matsuura et al., 1994). 293T cells (2 3 105
ells in a 35-mm plate) were transfected with 2 mg of
ach plasmid DNA in the presence of lipofectoamine
Gibco BRL, Life Technologies, Gaithersburg, MD) and
ncubated at 37°C.
estern blotting
Tn5 cells were harvested at 60 h after infection, cell
xtracts were separated by sodium dodecyl sulfate–poly-
crylamide gel electrophoresis, (SDS–PAGE), and pro-
eins were blotted to a polyvinylidene difluoride mem-
rane (Millipore, Tokyo, Japan). The immunoblot analysis
as carried out as described previously (Harada et al.,
991).
adiolabeling and immunoprecipitation
293T cells (2 3 105 cells in a 35-mm plate) transfected
ith expression plasmids were incubated for 24 h and
adiolabeled with 20 mCi of Tran 35S-label (ICN, Irvine,
A) for 4 h after 2 h of starvation with medium deficient
n FBS, methionine, and cysteine. Cells were washed
wice with 500 ml of phosphate-buffered saline, dissolved
n 400 ml of TNE buffer (10 mM Tris-HCl, pH 7.8, 150 mM
aCl, 1 mM EDTA, 1% NP-40, 10 mg of aprotinin/ml). Tn5
ells were infected with the recombinant baculovirus at a
ultiplicity of 5 PFU/cells in 35-mm tissue culture dishes
nd incubated at 26.5°C for 24 h. Each dish was radiora-
eled with 20 mCi of Tran 35S-label for 4 h after 2 h of
tarvation with TC-100 medium deficient in FBS, methio-
ine, and cysteine. Prior to immunoprecipitation, SDS
a
c
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322 SHOJI ET AL.nd dithiothreitol were added to the cell lysates to final
oncentrations of 2% and 10 mM, respectively. Cell lysate
100 ml) was suspended in 900 ml of TNE buffer and
ncubated with 0.5 ml of anti-NS2/NS3 or anti-NS3C poly-
lonal antibody and 20 ml of Protein A–Sepharose (Phar-
acia) (50% suspension (v/v) in TNE buffer) for 1 h at 4°C
ith rotating. After centrifugation at 8000 g for 10 s at
°C, pellets were washed twice with TNE buffer. The
mmunoprecipitates were analyzed by SDS–PAGE.
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